Salvianolic acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Min ^a   Sun, Guibo ^a   Wu, Ping ^b   Chen, Rongchang ^a   Yao, Fan ^c   Qin, Meng ^a   Luo, Yun ^a   Sun, Hong ^a   Zhang, Qiang ^d   Dong, Xi ^d   Sun, Xiaobo ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROCASPASE 3; PROTEIN BCL 2; SALVIANOLIC ACID B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CARDIOTOXICITY; CELL STRAIN HEPG2; CONTROLLED STUDY; HEART FUNCTION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; WESTERN BLOTTING;

EID: 84877248521     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/759483     Document Type: Article

References (29)

1. Zhu J., Chen Z., Lallemand-Breitenbach V., de Thé H., How acute promyclocytic leukaemia revived arsenic. Nature Reviews Cancer 2002 2 9 705 713 2-s2.0-0036715589 10.1038/nrc887 (Pubitemid 37328921)
2. Lengfelder E., Hofmann W. K., Nowak D., Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 2012 26 3 433 442
3. Ohnishi K., Yoshida H., Shigeno K., Nakamura S., Fujisawa S., Naito K., Shinjo K., Fujita Y., Matsui H., Takeshita A., Sugiyama S., Satoh H., Terada H., Ohno R., Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Annals of Internal Medicine 2000 133 11 881 885 2-s2.0-0034610263
4. Unnikrishnan D., Dutcher J. P., Varshneya N., Lucariello R., Api M., Garl S., Wiernik P. H., Chiaramida S., Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 2001 97 5 1514 1516 2-s2.0-0035283137 10.1182/blood.V97.5.1514 (Pubitemid 32183782)
5. Naito K., Kobayashi M., Sahara N., Shigeno K., Nakamura S., Shinjo K., Tobita T., Takeshita A., Ohno R., Ohnishi K., Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy. International Journal of Hematology 2006 83 4 318 323 2-s2.0-33744464511 10.1532/IJH97.05056 (Pubitemid 43807576)
6. Chang S. I., Jin B., Youn P., Park C., Park J. D., Ryu D. Y., Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicology and Applied Pharmacology 2007 218 2 196 203 2-s2.0-33846622398 10.1016/j.taap.2006.11.009 (Pubitemid 46177170)
7. Zhao X. Y., Li G. Y., Liu Y., Chai L. M., Chen J. X., Zhang Y., Du Z. M., Lu Y. J., Yang B. F., Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. The British Journal of Pharmacology 2008 154 1 105 113 2-s2.0-42949148136 10.1038/bjp.2008.81 (Pubitemid 351620407)
8. Das A. K., Sahu R., Dua T. K., Bag S., Gangopadhyay M., Sinha M. K., Dewanjee S., Arsenic-induced myocardial injury: protective role of Corchorus olitorius leaves. Food and Chemical Toxicology 2010 48 5 1210 1217 2-s2.0-77951622266 10.1016/j.fct.2010.02.012
9. Manna P., Sinha M., Sil P. C., Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Archives of Toxicology 2008 82 3 137 149 2-s2.0-41849147561 10.1007/s00204-007-0272-8
10. Chen J., Wang F., Lee F. S. C., Wang X., Xie M., Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis. Talanta 2006 69 1 172 179 2-s2.0-31544454713 10.1016/j.talanta.2005.09.041 (Pubitemid 43165520)
11. Zhou L., Chow M., Zuo Z., Improved quality control method for Danshen products-Consideration of both hydrophilic and lipophilic active components. Journal of Pharmaceutical and Biomedical Analysis 2006 41 3 744 750 2-s2.0-33646417027 10.1016/j.jpba.2005.12.032
12. Zhao G. R., Zhang H. M., Ye T. X., Xiang Z. J., Yuan Y. J., Guo Z. X., Zhao L. B., Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food and Chemical Toxicology 2008 46 1 73 81 2-s2.0-36848999824 10.1016/j.fct.2007.06.034 (Pubitemid 350235754)
13. Xu L., Deng Y., Feng L., Cardio-protection of salvianolic acid B through inhibition of apoptosis network. PLoS One 2011 6 9, article e24036
14. Wang Q. L., Tao Y. Y., Yuan J. L., Shen L., Liu C. H., Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF- β 1 signal transduction pathway in vivo and in vitro. BMC Cell Biology 2010 11, article 31 2-s2.0-77951777413 10.1186/1471-2121-11-31
15. Wang M., Sun G. B., Sun X., Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway. Toxicology Letters 2013 216 2-3 100 107
16. Rajadurai M., Prince P. S. M., Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. Toxicology 2007 230 2-3 178 188 2-s2.0-33846197152 10.1016/j.tox.2006.11.053 (Pubitemid 46109139)
17. Nakahara C., Nakamura K., Yamanaka N., Baba E., Wada M., Matsunaga H., Noshiro H., Tanaka M., Morisaki T., Katano M., Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear Factor- B activation in human gastric carcinoma cells. Clinical Cancer Research 2003 9 14 5409 5416 2-s2.0-10744222962 (Pubitemid 37413597)
18. Chou W. C., Dang C. V., Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Current Opinion in Hematology 2005 12 1 1 6 2-s2.0-13244267274 10.1097/01.moh.0000148552.93303.45 (Pubitemid 40189232)
19. Kumazaki M., Ando H., Sasaki A., Koshimizu T. A., Ushijima K., Hosohata K., Oshima Y., Fujimura A., Protective effect of α -lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats. Journal of Pharmacological Sciences 2011 115 2 244 248 2-s2.0-79952352284 10.1254/jphs.10280SC
20. Saad S. Y., Alkharfy K. M., Arafah M. M., Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats. Journal of Pharmacy and Pharmacology 2006 58 4 567 573 2-s2.0-33645566250 10.1211/jpp.58.4.0017
21. Hao Y., Xie T., Korotcov A., Zhou Y., Pang X., Shan L., Ji H., Sridhar R., Wang P., Califano J., Gu X., Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. International Journal of Cancer 2009 124 9 2200 2209 2-s2.0-63449093839 10.1002/ijc.24160
22. Guo L., Lei C. K., Shan M., Study of growth inhibitory effect and apoptosis induced by different matches of Tanshinone IIA and Salvianolic Acid B on Acute Promyelocytic Leukemia cells (HL-60). Journal of Chinese Medicinal Materials 2008 31 10 1512 1514 2-s2.0-70350765095
23. Wang Q. L., Wu Q., Tao Y. Y., Liu C. H., El-Nezami H., Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells. Hepatobiliary and Pancreatic Diseases International 2011 10 5 502 508
24. Li X., Darzynkiewicz Z., Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Experimental Cell Research 2000 255 1 125 132 2-s2.0-0034712259 10.1006/excr.1999.4796 (Pubitemid 30115295)
25. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G., Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Research 1993 53 17 3976 3985 2-s2.0-0027255417 (Pubitemid 23267698)
26. Xu Y., Liu Z., Sun J., Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. PLoS One 2011 6 12, article e28335
27. Yuan Z., Wang F., Zhao Z., Zhao X., Qiu J., Nie C., Wei Y., Bim-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells. PLoS ONE 2011 6 5 2-s2.0-79957851071 10.1371/journal.pone.0020586 e20586
28. Kang P. M., Yue P., Izumo S., New insights into the role of apoptosis in cardiovascular disease. Circulation Journal 2002 66 1 1 9 2-s2.0-0036242344 10.1253/circj.66.1 (Pubitemid 34462424)
29. Liu J., Chen B., Lu Y., Guan Y., Chen F., JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure. Toxicological Sciences 2012 129 2 363 371